EUVIMEDSkopri EUVIMED
Crossref

Faecal immunochemical test demonstrates modest decline in performance characteristics but additional prognostic roles: An evaluation in a symptomatic primary care cohort

Matthew Kurien, Mohamed El-Siddig, Daniel James Taylor, Ulla Elfadil, Alex John Ball iD

Colorectal Disease · 2025

DOI: 10.1111/codi.70297 ↗

At a glance

Journal article in Colorectal Disease, 2025. Written by Matthew Kurien and 4 co-authors. Institution: Department of Gastroenterology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Major MEDLINE topics: Colorectal Neoplasms, Occult Blood, Early Detection of Cancer. Cited 1 times so far (Crossref); 23 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aim

To evaluate long‐term colorectal cancer (CRC) incidence and faecal immunochemical test (FIT) performance in patients with low‐risk symptoms over 5 years, and to examine factors influencing outcomes and mortality.

Method

We followed 3501 symptomatic patients who underwent FIT in primary care (October–December 2019) across 225 practices in England. Building on our 18‐month study, patients were tracked for 5 years using primary and secondary care records to identify new cancers and deaths.

Results

Ten additional CRCs were diagnosed during extended follow‐up (18–60 months), beyond the 45 identified in the first 18 months. Seven of these had initial negative FIT results. FIT sensitivity at ≥10 μg/g fell from 94.1% at 18 months to 80.0% (95% CI 67.0–89.6%) at 5 years, while specificity was 80.8% (95% CI 79.4–82.1%). The positive predictive value was 6.2% (95% CI 5.4–7.2%) and the negative predictive value 99.6% (95% CI 99.3–99.8%). Patients with negative FITs experienced a significantly longer time to CRC diagnosis than those with positive FITs (median 28 vs 1 month, HR 16.4, p < 0.001). Positive FITs were also linked to higher overall cancer risk (HR 1.63, p = 0.0076) and greater 5‐year mortality (24.9% vs 11.9%, HR 2.8, p < 0.001).

Conclusion

FIT performance decreases over longer follow‐up, with 12.7% of CRCs detected after initially negative results. Positive FITs were associated with increased mortality and overall cancer risk. These findings highlight the importance of robust safety‐netting strategies for patients with negative FIT results.

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsOccult BloodEarly Detection of CancerHumansFemaleMalePrimary Health CareMiddle AgedAgedPrognosisEnglandPredictive Value of TestsSensitivity and SpecificityIncidenceTime Factors

Author keywords

colorectal cancerdiagnostic testingmortality

Authors and institutions

  • Department of Gastroenterology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Medical School, Sheffield, UK.

ORCID profiles: Alex John Ball

Cite

APA

Kurien, M., El-Siddig, M., Taylor, D. J., Elfadil, U., & Ball, A. J. (2025). Faecal immunochemical test demonstrates modest decline in performance characteristics but additional prognostic roles: An evaluation in a symptomatic primary care cohort. Colorectal Disease. https://doi.org/10.1111/codi.70297

Vancouver

Kurien M, El-Siddig M, Taylor DJ, Elfadil U, Ball AJ. Faecal immunochemical test demonstrates modest decline in performance characteristics but additional prognostic roles: An evaluation in a symptomatic primary care cohort. Colorectal Disease. 2025. doi:10.1111/codi.70297

BibTeX
@article{Kurien2025,
  author = {Kurien, Matthew and El-Siddig, Mohamed and Taylor, Daniel James and Elfadil, Ulla and Ball, Alex John},
  title = {Faecal immunochemical test demonstrates modest decline in performance characteristics but additional prognostic roles: An evaluation in a symptomatic primary care cohort},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.70297}
}
Start for free →